Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2017-09-04 Capital/Financing Update
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Strategic Transaction Update 1 page 243.7KB
Capital/Financing Update Classification · 95% confidence The document is a media announcement from Invion Limited regarding a determination by the Australian Securities Exchange (ASX) about specific listing rules not applying to a previously announced strategic transaction. It references a transaction update and an indicative timetable but does not contain financial statements, detailed financial data, or comprehensive report content. The document is short (863 characters) and serves as an update or announcement rather than a full report or detailed filing. It is not a full Annual Report, Interim Report, or Earnings Release. It is also not a regulatory certification or officer attestation. The content fits best under Capital/Financing Update (CAP) as it relates to a strategic transaction and ASX listing rule determinations affecting the company's capital or financing activities.
2017-09-04 English
Trading Halt 2 pages 335.4KB
Regulatory Filings Classification · 95% confidence The document is a market release dated 1 September 2017 from Invion Limited regarding a trading halt request. It references compliance with ASX Listing Rules and the pending determination by ASX about a transaction announced on 31 August 2017. The document is short (1928 characters) and primarily serves as an announcement of a trading halt rather than a detailed report or financial statement. There is no financial data, no detailed report content, and no indication of a report being attached or published. The content fits best under a regulatory announcement category related to trading status and compliance, which aligns with Regulatory Filings (RNS).
2017-08-31 English
Invion announces strategic transaction 3 pages 100.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX media announcement detailing a strategic transaction involving Invion Limited and The Cho Group Limited. It describes agreements for exclusive commercialization and distribution rights, R&D services, and an underwriting agreement for a pro rata entitlement offer. The document includes information about the transaction process, conditions precedent, an independent expert's report, board restructuring, and an indicative timetable for completion. It is a public announcement of a financing and strategic partnership transaction, including a capital raise via entitlement offer. There are no financial statements or detailed financial performance data presented, nor is it a report or transcript. The content fits best under Capital/Financing Update (CAP) as it announces financing activities and capital structure changes related to the transaction.
2017-08-30 English
Appendix 4E and Full Year Statutory Accounts 58 pages 974.7KB
Annual Report Classification · 100% confidence The document is titled 'Appendix 4E – Final Report' for the financial year ended 30 June 2017, which is a regulatory filing format used in Australia for annual financial results. It includes detailed financial data such as revenue, net profit, dividends, earnings per share, and net tangible assets per share. The document also contains a Directors' Report, consolidated financial statements, notes, auditor's report, and other comprehensive financial disclosures typical of a full annual report. The length of the document (15,000 characters) and the presence of substantive financial statements and analysis confirm it is not merely an announcement or summary. The inclusion of an independent auditor's report and detailed financial statements aligns with the characteristics of an Annual Report (10-K equivalent). Therefore, the document should be classified as an Annual Report (10-K). FY 2017
2017-08-30 English
Appendix 4C - quarterly 6 pages 100.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'APPENDIX 4C' and is described as a quarterly report for entities subject to Listing Rule 4.7B. It contains detailed consolidated statements of cash flows for the quarter ended 30 June 2017, including operating, investing, and financing activities, cash balances, payments to directors, and estimated cash outflows for the next quarter. The document is over 10,000 characters, indicating it is a substantive financial report rather than a brief announcement. The Appendix 4C is a recognized quarterly cash flow report required by the ASX for listed entities, which aligns with the definition of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and contains actual financial data and analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q4 2017
2017-07-30 English
Appendix 3Y - Dr J Campbell 3 pages 75.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in the shareholdings of a company director, including direct and indirect interests, dates of changes, and nature of transactions. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades or director dealings. It does not contain financial statements, earnings data, or management commentary. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 4199 characters, which is consistent with a detailed insider trading notice rather than a full financial report or announcement.
2017-06-27 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.